Lily Lu
Impact in
- Immunology top 1%
- Immune cells in cancer
- Immune Cell Function and Interaction
- Complement system in diseases
- Immunotherapy and Immune Responses
- Transplantation top 2%
Papers in
- Immunology 13
- Immune cells in cancer 4
- Complement system in diseases 3
- Immune Response and Inflammation 3
- Oncology 11
- CAR-T cell therapy research 6
- Cytokine Signaling Pathways and Interactions 4
- Co-authors
- Dmitry I. Gabrilovich (3 shared papers)Matthew J. Cotter (2 shared papers)Je-In Youn (2 shared papers)Esteban Celis (1 shared paper)David Quiceno (1 shared paper)Pingyan Cheng (1 shared paper)Judith C. McCaffrey (1 shared paper)Hyun-Il Cho (1 shared paper)
- Journals
- Blood (2 papers)Clinical Cancer Research (2 papers)The Journal of Immunology (2 papers)Cancer Research (2 papers)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Lily Lu
24 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Immunology 1.6k
- Transplantation 162
- Oncology 931
- Nephrology 205
- Pharmacology 468
Countries citing papers authored by Lily Lu
This map shows the geographic impact of Lily Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lily Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lily Lu more than expected).
Fields of papers citing papers by Lily Lu
This network shows the impact of papers produced by Lily Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lily Lu. The network helps show where Lily Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Lily Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment Hit paper breakdown → | 2010 | 930 |
| 2 | 2003 | 416 | |
| 3 | Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor–transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma Hit paper breakdown → | 2019 | 301 |
| 4 | 2010 | 225 | |
| 5 | 2013 | 174 | |
| 6 | 2013 | 169 | |
| 7 | 2013 | 93 | |
| 8 | 2003 | 69 | |
| 9 | 2011 | 65 | |
| 10 | 2011 | 59 | |
| 11 | 2011 | 53 | |
| 12 | 2009 | 53 | |
| 13 | 2016 | 49 | |
| 14 | 2012 | 33 | |
| 15 | 2017 | 28 | |
| 16 | 2014 | 23 | |
| 17 | 2013 | 18 | |
| 18 | 2011 | 14 | |
| 19 | 2010 | 10 | |
| 20 | 2001 | 2 |
About Lily Lu
Lily Lu is a scholar working on Immunology, Oncology, Molecular Biology, Rheumatology and Nephrology, having authored 25 papers that have together received 2.8k indexed citations. Recurring topics across this work include CAR-T cell therapy research (6 papers), Cytokine Signaling Pathways and Interactions (4 papers), Immune cells in cancer (4 papers), Complement system in diseases (3 papers), Renal Diseases and Glomerulopathies (3 papers), Immune Response and Inflammation (3 papers), Systemic Lupus Erythematosus Research (3 papers) and Cannabis and Cannabinoid Research (2 papers). The work is most often cited by research in Immunology (1.6k citations), Transplantation (162 citations), Oncology (931 citations), Nephrology (205 citations) and Pharmacology (468 citations). Lily Lu has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Dmitry I. Gabrilovich, Matthew J. Cotter, Je-In Youn, Esteban Celis, David Quiceno, Pingyan Cheng, Judith C. McCaffrey, Hyun-Il Cho, Tapan Padhya and Thomas Condamine. Their work appears in journals such as Blood, Clinical Cancer Research, The Journal of Immunology, Cancer Research and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.